Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

45.54USD
15 Feb 2019
Change (% chg)

$1.04 (+2.34%)
Prev Close
$44.50
Open
$44.74
Day's High
$45.66
Day's Low
$44.36
Volume
154,081
Avg. Vol
257,112
52-wk High
$82.68
52-wk Low
$33.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -1.862
Jun '18 0.00 -1.707
Mar '18 0.00 -1.734
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 19.22 76.88 0.00 --
Quarter Ending Jun-19 4 0.47 1.88 0.00 --
Year Ending Dec-19 12 44.38 150.00 0.00 41.67
Earnings (per share)
Quarter Ending Mar-19 5 -0.84 1.28 -1.56 --
Quarter Ending Jun-19 5 -1.38 -1.27 -1.49 --
Year Ending Dec-19 13 -4.79 -1.29 -8.62 -5.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 2.67 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 8.24 10.14 5.26
Price to Tangible Book (MRQ) 9.37 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -208.10 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -138.27 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate 22.82 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 5.52 3.50 3.08
LT Debt to Equity (MRQ) 0.09 18.65 11.38
Total Debt to Equity (MRQ) 1.24 31.33 16.12
Interest Coverage (TTM) -120.23 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.40 12.87
Operating Margin (TTM) -- -184.63 6.20
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -- -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.68 8.61
Net Profit Margin (TTM) -- -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,654,601 842,398,385
Net Income/Employee (TTM) -2,959,909 562,114 99,842,801
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.29 6.39 11.06
Return on Assets - 5 Yr. Avg. -30.70 5.47 12.20
Return on Investment (TTM) -61.42 8.92 14.45
Return on Investment - 5 Yr. Avg. -32.77 6.78 15.87
Return on Equity (TTM) -61.71 10.08 15.96
Return on Equity - 5 Yr. Avg. -35.99 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -47.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.55 7.70 99 99
13 Week 20.24 14.38 99 95
26 Week 56.92 44.99 99 98
52 Week 315.45 252.13 99 72
YTD 348.96 294.28 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 212
Total Shares Held: 28,874,752
3 Mo. Net Change: -1,318,779
# New Positions: 34
# Closed Positions: 30
# Increased Positions: 97
# Reduced Positions: 90
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.